Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

won't touch this with conversions in-play:

8K dated 11/18/16:

"On October 18, 2016, the Company entered into two $500,000 0% convertible promissory notes (the “Convertible Notes”) for advisory services each of which are due and payable on October, 182017. The Notes will be converted on April 18, 2017 ( the “Conversion Date”) into the Company’s common stock (the “Shares”) in the amount of a) US$500,000 (“Principal Amount" using the fixed price per share of $0.025/share (the “Conversion Price”) to determine the number of shares to be delivered."

PR dated 2/17/17:

"In consideration for Restructuring Services provided by BMI, Amarantus has issued a 0% convertible promissory note with an aggregate value of US$500,000 (the "Convertible Note". The Convertible Note may be converted into shares in Amarantus at a conversion price of US$0.025 per share on or within 12 months from the date of issuance i.e. 18 October 2016 subject to five (5) days prior written notice to Amarantus. If the Convertible Note is not converted into shares in Amarantus on or before 17 October 2017, the Convertible Note shall be converted into shares in Amarantus on 18 October 2017 at a conversion price of US$0.025 per share."